Tenax Therapeutics, Inc. (TENX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$10.37
Day's range
$11.82

Tenax Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 2.95 M $47.19 M   100.00% 7.53%
JANUS HENDERSON GROUP PLC 05/18/2026 1.82 M $29.07 M   989.29% 4.63%
VR ADVISER, LLC 05/15/2026 1.68 M $26.79 M   100.00% 4.27%
PERCEPTIVE ADVISORS LLC 05/29/2026 1.45 M $23.15 M   229.68% 3.69%
IKARIAN CAPITAL, LLC 05/15/2026 1.02 M $16.27 M   5.17% 2.59%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 975.20 K $15.59 M   8,105.99% 2.49%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 625.00 K $9.99 M   100.00% 1.59%
MORGAN STANLEY 05/15/2026 596.56 K $9.54 M   0.03% 1.52%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2026 583.33 K $9.33 M   600.00% 1.49%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 540.13 K $8.64 M   548.15% 1.38%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 533.97 K $8.54 M   26.11% 1.36%
MILLENNIUM MANAGEMENT LLC 05/15/2026 533.89 K $8.54 M   76.51% 1.36%
ARMISTICE CAPITAL, LLC 05/15/2026 478.83 K $7.66 M   100.00% 1.22%
SIREN, L.L.C. 05/14/2026 427.14 K $6.83 M   0.00% 1.09%
TD ASSET MANAGEMENT INC 05/11/2026 399.18 K $6.38 M   100.00% 1.02%
UBS GROUP AG 05/05/2026 381.42 K $6.10 M   56,322.93% 0.97%
RTW INVESTMENTS, LP 05/15/2026 370.25 K $5.92 M   -2.14% 0.94%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 366.79 K $5.86 M   4.14% 0.94%
MARSHALL WACE, LLP 05/15/2026 352.57 K $5.64 M   18.25% 0.90%
BVF INC/IL 05/15/2026 339.55 K $5.43 M   0.00% 0.87%
GREAT POINT PARTNERS LLC 05/15/2026 327.31 K $5.23 M   100.00% 0.83%
WOODLINE PARTNERS LP 05/15/2026 323.91 K $5.18 M   125.75% 0.83%
FMR LLC 05/15/2026 322.60 K $5.16 M   128.63% 0.82%
AMERIPRISE FINANCIAL INC 05/15/2026 279.54 K $4.47 M   100.00% 0.71%
05/15/2026 263.42 K $4.21 M   100.00% 0.67%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 215.93 K $3.45 M   100.00% 0.55%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 213.46 K $3.41 M   235.25% 0.54%
VIVO CAPITAL, LLC 05/20/2026 208.33 K $3.33 M   0.00% 0.53%
BOONE CAPITAL MANAGEMENT LLC 05/15/2026 200.00 K $3.20 M   100.00% 0.51%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 194.62 K $3.11 M   100.00% 0.50%
STEMPOINT CAPITAL LP 05/18/2026 188.70 K $3.02 M   100.00% 0.48%
DIADEMA PARTNERS LP 05/15/2026 179.74 K $2.87 M   -26.09% 0.46%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 167.00 K $2.67 M   0.00% 0.43%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 152.60 K $2.44 M   21.52% 0.39%
CITADEL ADVISORS LLC 05/15/2026 152.52 K $2.44 M   17.75% 0.39%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 136.02 K $2.17 M   -28.46% 0.35%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2026 120.53 K $1.93 M   100.00% 0.31%
IKARIAN CAPITAL, LLC 05/15/2026 114.30 K $1.83 M   100.00% 0.29%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 104.40 K $1.67 M   100.00% 0.27%
VERDAD ADVISERS, LP 05/15/2026 95.33 K $1.52 M   100.00% 0.24%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 69.16 K $1.11 M   24.17% 0.18%
TWO SIGMA INVESTMENTS, LP 05/15/2026 68.59 K $1.10 M   104.92% 0.17%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 62.79 K $1.00 M   100.00% 0.16%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 58.18 K $930.33 K   -10.86% 0.15%
VESTAL POINT CAPITAL, LP 05/15/2026 53.44 K $854.49 K   0.00% 0.14%
TREXQUANT INVESTMENT LP 05/15/2026 50.71 K $810.89 K   100.00% 0.13%
XTX TOPCO LTD 05/15/2026 47.85 K $765.14 K   100.00% 0.12%
05/15/2026 45.00 K $719.55 K   100.00% 0.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 44.90 K $717.95 K   0.00% 0.11%
ARTIA GLOBAL PARTNERS LP 05/15/2026 42.08 K $672.86 K   0.00% 0.11%

Tenax Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 83 institutional investors and hedge funds held shares of Tenax Therapeutics Inc. The most heavily invested institutionals were:

PRICE T ROWE ASSOCIATES INC /MD/: 2.95 M

JANUS HENDERSON GROUP PLC: 1.82 M

VR Adviser, LLC: 1.68 M

PERCEPTIVE ADVISORS LLC: 1.45 M

Ikarian Capital, LLC: 1.02 M

Stonepine Capital Management, LLC: 975,200

54.12% of Tenax Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 21.19 M shares in the last 24 months. This purchase volume represents approximately $233.57 M in transactions.